Reliance Securities
A Reliance Capital Company
Welcome,
Guest
FAQ's
|
Contact us
|
Careers
|
Open an Account
|
Site Map
|
Login
Home
Our Offerings
Markets
Mutual Fund
News
Research
Trading
Customer Service
Partner with us
About us
Media Center
Knowledge Center
Open an Account
Products
RSP Plan
NRI Services
Sub Broker
AMO
Shares as Collateral
PMS
Online Trading
Call and Trade
Mobile Trading
Walk-in
How to Login
Equity
Derivatives
Currency
IPO
Top Performing Funds/Schemes
View Snapshot
Fund Comparison
SIP Calculator
News
MF fees disclosure
Important Submission
Equity
Mutual Fund
IPO
Advance Search
Market Outlook
Research on SMS
Budget'10-11
Investment Idea
Branch locator
Download forms
Open an account
Feedback
Reset Security Token
Trading Holidays
Charges
Track Your Application
Why Join Us
Apply Now
Regular Stock Purchase Plan (RSP Plan) – A disciplined and easy way to invest in the equity market. Click here
News
Equity news
Jul 01 2011 01:31 PM
Hindusthan National Glass sees a surge in volume
Mukand, Aventis Pharma, Deep Industries and Prime Focus are among the other stocks to see a surge in volumes on BSE today, 1 July 2011.
Jul 01 2011 01:29 PM
RIL drags market further lower
Jul 01 2011 01:10 PM
Gemini Communication rings loud as board to consider share buyback
Gemini Communication soared 5.22% to Rs 24.20 at 13:08 IST on BSE, after the company said its board will meet on 18 July 2011 to consider buyback of its own shares.
Jul 01 2011 01:01 PM
Exports rise 45.28% in first two months of FY12
Imports register a growth of 33.30% for the period of April-May 2011-12
Jul 01 2011 12:56 PM
Urja Global to announce financial results
Board meeting on 07 July 2011
Jul 01 2011 12:53 PM
Telesys Software reports net loss of Rs 0.44 crore in the March 2011 quarter
No sales reported during the quarter
Jul 01 2011 12:50 PM
Fitch: Euro Area Crisis Continues to Overshadow Global Credit Outlook
Jul 01 2011 12:48 PM
Muthoot Capital Services to issue equity shares
Board meeting on 02 July 2011
Jul 01 2011 12:27 PM
Wockhardt hardens on US nod for a generic drug
Wockhardt gained 1.46% to Rs 372 at 12:25 IST on BSE, after the company received tentative approval from the US drug regulator to market 0.1% solution of Olopatadine hydrochloride eye drops.
Jul 01 2011 12:27 PM
Market slips into the red; breadth positive
Page: 1 of 5
Company Search
Quotes
News
Profile
New Trading Platforms
Insta Plus
View Insta Plus Demo
How to Login
Terms & Conditions
|
Disclaimer
|
Online Privacy
|
Trouble Logging in
|
Glossary
|
Sitemap